American Association for the Advancement of Science, Science Translational Medicine, 535(12), 2020
DOI: 10.1126/scitranslmed.aaz8235
Full text: Unavailable
A strong vaccine-induced T cell response during standard-of-care chemotherapy correlates with survival in patients with advanced cervical cancer.